InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Status Update Regarding Listing, Strategic Direction
January 3, 2024
Nemaura Medical (NASDAQ: NMRD), a developer of a daily-wear, noninvasive glucose sensor and digital healthcare programs, is reporting on decisions that will impact its listing status on the NASDAQ Capital Market; the company also released key information regarding its broader strategic direction. According to the announcement, the company’s management team and medical board of directors has […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Positive Nasdaq Listing Decision
December 13, 2023
Nemaura (NASDAQ: NMRD), developer of a daily wear non-invasive glucose sensor and digital health care programs, today announced that the Nasdaq Hearings Panel granted the company’s request for continued listing pursuant to an exception, including certain interim milestones, that ultimately expires on April 1, 2024, to evidence compliance with all applicable criteria for continued listing […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures $10M Credit Facility to Drive Growth
November 21, 2023
Nemaura (NASDAQ: NMRD), developer of a daily wear non-invasive glucose sensor and digital health care programs, today announced the execution of a strategic agreement for a $10 million credit facility, which is expected to support the company’s strategic growth plans. Nemaura recognizes the challenges associated with equity sales, particularly in the small-cap landscape on the […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q3 2023 Report, Unveils New Direct-to-Consumer Metabolic Health Program Offering
November 14, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, is reporting on its financial and business results for the quarter ended Sept. 30, 2023, and providing a business update. Corporate highlights of the report show continued support of its United […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Appointment of Strategic AI Advisor
September 26, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, has appointed artificial intelligence (“AI”) specialist Nikolai Rozanov as strategic adviser in the company’s AI development. According to the announcement, Rozanov will assist in development of Nemaura’s AI health coach and […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Emerging Growth in A.I. Conference
September 18, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that its CEO Dr. Faz Chowdhury will present business updates and developments at the Maxim Group Emerging Growth in A.I. virtual conference. Dr. Chowdhury’s presentation is scheduled to […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
September 14, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with continued listed standards and anticipated next steps to maintain its listing on the Nasdaq Capital Market. As previously announced, Nemaura was notified […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Interim Results from Its Miboko Program
September 13, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced interim results from its metabolic health program. According to the update, the primary objective of the study was to establish whether a metabolic program with a daily wear CGM worn twice […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at HLTH 2023
September 12, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting diabetes management and personalized lifestyle coaching programs. The company today announced that it will be participating at the HLTH 2023 conference, which is taking place in Las Vegas in October. The company’s attendance is in response […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Interim Results for 100-Patient Study for sugarBEAT(R)
September 11, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs. The company today announced its recent completion of a 100-patient study across four cohorts of 25 diabetic patients for sugarBEAT(R) and provided interim results. Nemaura previously received CE approval in […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures SFDA Approval for sugarBEAT(R)
August 17, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today announced SFDA (Saudi Food and Drug Authority) approval of sugarBEAT(R), its non-invasive wearable glucose sensor. According to the update, the news comes after a year of liaisons with the SFDA […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Financial, Business Report
August 15, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, is reporting its financial and business results for the quarter ended June 30, 2023. Corporate highlights of the report include initial patient data from UK National Health Service (“NHS”) Miboko […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports on $6.5M Non-Dilutive Funding
August 14, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, has secured an additional $6.5 million in nondilutive funding. The company announced the funding was secured through a clean debt facility with no warrants or convertible elements from an existing lender. In […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Fiscal Year Financial Report, Corporate Update
July 14, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, is reporting its financial results for the fiscal year ended March 31, 2023. The report showed R&D expenses totaled an estimated $1.5 million, which was consistent with the prior year; […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Takes Another Step in Commercialization of proBEAT(TM) Platform
June 27, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, today announced the next commercialization stage of its proBEAT(TM) sensor and AI-based feedback platform, augmenting the BEAT(TM) diabetes program. Intended as a precursor to revenue-generating contracts for proBEAT, the pilots will commence over the coming weeks and months. […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Collision Conference
June 22, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on non-invasive wearable sensors and personalized weight reduction programs, today announced that it will be participating at the upcoming Collision Conference. The event, being held at the Enercare Centre in Toronto, Canada, on June 26-29, 2023, brings together leading technology companies and an expected 40,000 attendees and […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Showcase Technology at World’s Premier Diabetes Education Event
June 15, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs. The company today announced that it will exhibit and provide product demonstrations of its non-invasive daily-wear glucose sensor platform at the 83rd Scientific Sessions of the American Diabetes Association. The […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participating in EF Hutton Fireside Chat
March 21, 2023
Nemaura Medical (NASDAQ: NMRD) CEO DR. Faz Chowdhury will be participating in a fireside chat hosted by EF Hutton research analyst Constantine Davides. The medical technology company, which is focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, announced that the executive will be involved in the […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Expands EU DuoPack Agreement by Including Insulin as Eligible Drug
March 15, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, has added insulin onto the list of drugs under the DuoPack Commercial License Agreement with its licensee, MySugarWatch DuoPack Limited (“MSWDL”). Last September, Nemaura and MSWDL announced a commercial agreement making […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Q3 2023 Results, Provides Business Update
February 24, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable sensors and supporting personalized lifestyle and weight reduction programs. The company today released its financial results for the quarter ending Dec. 31, 2022, and provided a business update. “We continue to build momentum with our U.K. programs, while initiating our […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference
February 16, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs. The company today announced that its CEO Dr. Faz Chowdhury will participate in a fireside chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference that is being held virtually […]
Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
February 8, 2023
Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
January 31, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs. The company today announced the close of its registered direct offering with two health care-focused U.S. institutional investors to sell 4,796,206 shares of its common stock and warrants to purchase up […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
January 27, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs. The company today announced its entry into a definitive agreement with two health care-focused U.S. institutional investors to sell 4,796,206 shares of its common stock, pursuant to a registered direct offering, […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces $500K PO from U.S. Health Provider HealthFleet
January 26, 2023
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, has received a purchase order from HealthFleet Inc., a leading telehealth provider; the initial order is for 5,000 proBEAT(TM) subscriptions. According to the announcement, the full purchase order, valued at $500,000, […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
January 24, 2023
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, today announced initial results from patient studies of its metabolic health program Miboko with the National Health Service (“NHS”) in the United Kingdom. The initial pilot program recruited 30 individuals who were […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Sidoti & Co. Micro Cap Conference
January 11, 2023
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs. The company today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Sidoti & Co. Micro Cap Virtual Conference being held on Jan. 18 -19, […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Planet MicroCap Showcase: Virtual 2022
December 1, 2022
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Planet MicroCap Showcase: Virtual 2022. The event is slated to take place on Dec. 6 – 8, 2022, […]
InvestorNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Miboko Pilot Program Kicks Off in UK
November 29, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle and weight reduction programs, has begun patient studies of its proprietary metabolic health program, Miboko. The studies are being conducted with the National Health Service (“NHS”) in the United Kingdom. Miboko is the first metabolic […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Fiscal Q2 2023 Results, Provides Business Update
November 15, 2022
Nemaura (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today released its financial results for the quarter ending Sept. 30, 2022, and provided a business update. “Our commercial and manufacturing scale-up activities accelerated in the fiscal second quarter, as we […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) CEO to Present at Bernstein 2nd Annual CGM Disruptors Conference
November 11, 2022
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Bernstein 2nd Annual CGM Disruptors Conference, which is being held virtually on Nov. 18, 2022. […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Be Featured on the RedChip Money Report(R)
November 4, 2022
Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. RedChip Companies has announced that it will air a new interview with Nemaura on the RedChip Money Report(R) on Bloomberg TV at 7 p.m. Eastern Time on Nov. 5, 2022. Bloomberg TV […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Receives Provisional Purchase Order from Middle East Licensee
October 12, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its receipt of a provisional purchase order from TPMENA, its MENA (Middle East/North Africa) licensee for the company’s sugarBEAT(R) system. The order, which is contingent on receipt of Kingdom of […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming MicroCap Rodeo Windy City Roundup
October 4, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, will be participating in the MicroCap Rodeo Windy City Roundup 2022 Conference held in Chicago. Slated for Oct. 12–13, 2022, the two-day event will include a presentation by Nemaura Medical […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Collaborates with EVERSANA(R) to Bring BEATdiabetes Solution to Market
September 27, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its entry into a preliminary agreement with EVERSANA(R), a pioneer of next-gen commercial services to the global life sciences industry. The agreement covers the U.S. and all global sales and […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference
September 6, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, will be participating in the 24th annual H.C. Wainwright Global Investment Conference. Slated for Sept. 12–14, 2022, the three-day event will include a presentation by Nemaura Medical CEO Dr. Faz […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Report, Notes Purchase Agreement Highlight
August 15, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, has released Q1 2023 financial results for the quarter ending June 30, 2022; the company also noted that it entered into a new note purchase agreement in May 2022 as […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Featured in Bell2Bell Podcast
August 8, 2022
Nemaura Medical (NASDAQ: NMRD) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Faz Chowdhury, chairman and CEO of Nemaura, joined the latest episode to provide an introduction to Nemaura Medical and discuss its business model. “Nemaura Medical was founded just […]
IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Dr. Faz Chowdhury, CEO of Nemaura Medical Inc.
August 8, 2022
LOS ANGELES, Aug. 08, 2022 (GLOBE NEWSWIRE) — via InvestorWire — IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures UK Trademark for ‘Meta Score’
July 21, 2022
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today announced that it has been granted a U.K. trademark for “Meta Score.” The company intends to use Meta Score as the term for a digital biomarker for its consumer […]